Why the study?
Does gadolinium-enhanced T1-weighted MRI improve the depiction of lesions compared to noncontrast T1-weighted and T2-weighted MRI in a patient with rhabdomyolysis?
Does gadolinium-enhanced T1-weighted MRI improve the depiction of lesions compared to noncontrast T1-weighted and T2-weighted MRI in a patient with rhabdomyolysis?
Gadolinium-enhanced T1-weighted MRI may be more useful than T2-weighted or noncontrast T1-weighted imaging for diagnosing rhabdomyolysis in the chronic phase.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for gadolinium-enhanced T1 imaging in chronic rhabdomyolysis; prospective studies needed before clinical adoption.
Although T2-weighted magnetic resonance imaging (MRI) was reported to be useful for depicting rhabdomyolysis lesions, little is known as to the usefulness of gadolinium-enhanced T1-weighted imaging. The authors performed noncontrast and postcontrast T1-weighted MRI along with T2-weighted MRI in a patient with rhabdomyolysis in the chronic phase. Non-contrast T1-weighted imaging revealed no abnormality, whereas postcontrast T1-weighted imaging demonstrated lesions more definitively than T2-weighted imaging. Gadolinium-enhancement study may contribute to the MRI diagnosis of rhabdomyolysis.
No takes yet. Share an insight, caveat, or question.
Kakuda et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: